Inhibitory effect of pyridyloxy- or phenoxylphenoxyalkanate derivatives on rat lens aldose reductase and rat platelet aggregation

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 7, 2004, Pages 941-945

  Lim, Soon Sung ^a   Shin, Kuk Hyun ^b   Jung, Sang Hoon ^c   Shin, Kye Jung ^c   Kim, Dong Chang ^c   Park, Sang Woo ^c   Shin, Hyun Kyung ^a   Keum, Sam Rok ^d  

^a Hallym University   (South Korea)

^b Seoul National University   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

^d Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2,6 DICHLORO 3 METHYLPHENOXY) 3 NITROPHENOXY]PROPIONIC ACID; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; COLLAGEN; PHENOXYLPHENOXYPROPIONIC ACID DERIVATIVE; PROPIONIC ACID DERIVATIVE; PYRIDYLOXYPHENOXYPROPIONIC ACID DERIVATIVE; TETRAMETHYLENEGLUTARIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG POTENCY; DRUG SYNTHESIS; IC 50; LENS; MALE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION;

ALDEHYDE REDUCTASE; ANIMALS; BENZENE DERIVATIVES; LENS, CRYSTALLINE; MALE; PLATELET AGGREGATION; PROPIONIC ACIDS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 3042730809     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357023664     Document Type: Article

References (16)

1. Colwell, J. A., Winocour, P. D., Halushka, P. V. (1983) Do platelets have anything to do with diabetic microvascular disease? Diabetes 32 (suppl. 2): 14-19
2. Gabbasov, Z. A., Popov, E. G., Gavrilov, I. Y., Posin, E. Y. (1989) Platelet aggregation: the use of optical density fluctuations to study microaggregate formation in platelet suspension. Thromb. Res. 54: 215-223
3. Galvez, A. S., Ulloa, J. A., Chiong, M., Criollo, A., Eisner, V., Barros, L. F., Lavandero, S. (2003) Aldose reductase induced by hyperosmotic stress mediates cardiomyocyte apoptosis: differential effects of sorbitol and mannitol. J. Biol. Chem. 278: 38484-38494
4. Hayman, S., Kinoshita, J. H. (1965) Isolation and properties of lens aldose reductase. J. Biol. Chem. 240: 877-882
5. Inagaki, K., Miwa, I., Okuda, J. (1982) Affinity purification and glucose specificity of aldose reductase from bovine lens. Arch. Biochem. Biophys. 216: 337-344
6. Kador, P. F., Kinoshita, J. H., Sharpless, N. E. (1985) Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications. J. Med. Chem. 28: 841-849
7. Lee, Y. S., Pearlstein, R., Kador, P. F. (1994) Molecular modeling studies of aldose reductase inhibitors. J. Med. Chem. 37: 787-792
8. Lee, Y. S., Chen, Z., Kador, P. F. (1998) Molecular modeling studies of the binding modes of aldose reductase inhibitors at the active site of human aldose reductase. Bioorg. Med. Chem. 6: 1811-1819
9. Lim, S. S., Jung, S. H., Ji, J., Shin, K. H., Keum, S. R. (2000) Inhibitory effects of 2′-hydroxychalcones on rat lens aldose reductase and rat platelet aggregation. Chem. Pharm. Bull. 48: 1786-1789
10. Lim, S. S., Jung, S. H., Ji, J., Shin, K. H., Keum, S. R. (2001) Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues. J. Pharm. Pharmacol. 53: 653-668
11. May, J., Loesche, W., Heptinstall, S. (1990) Glucose increases spontaneous platelet aggregation in whole blood. Thromb. Res. 59: 489-495
12. Sato, S., Kador, P. F. (1990) Inhibition of aldehyde reductase by aldose reductase inhibitors. Biochem. Pharmacol. 40: 1033-1042
13. Shin, K. H., Lee, E. B., Park, S. W., Shin, K. J., Kim, D. C., Kim, D. J. (1997) Synthesis and anti-inflammatory and analgesic activities of phenoxyalkanoic acid derivatives. Arch. Pharm. Res. 20: 72-75
14. Shin, K. H., Lim, S. S., Jung, S. H., Ji, Jun, Lee, E. B., Kim, D. C., Shin, K. J., Kim, D. J., Park, S. W. (2000) Synthesis and anti-inflammatory and analgesic activities of pyridyloxy- and phenoxyalkanoic acid derivatives. Arch. Pharm. Res. 23: 17-21
15. Tomlinson, D. R., Stevens, E. J., Diemel, L. T. (1994) Aldose reductase inhibitors and their potential for the treatment of diabetic complications. Trends Pharmacol. Sci. 15: 293-297
16. Zatz, R., Brenner, B. M. (1986) Pathogenesis of diabetic microangiopathy. The hemodynamic view. Am. J. Med. 80: 443-453